A survey on pulmonary pathogens and their antibiotic susceptibility among cystic fibrosis patients
Authors: Ghamartaj Khanbabaeea1; Majidreza Akbarizadeh2; Aliakbar Sayyari3; Mitra Ashayeri-Panah4; Fatemeh Abdollahgorji5; Kourosh Sheibani6; Nima Rezaei7
Descriptors: Cystic fibrosis; Respiratory tract infections; Products with antimicrobial action
How to cite this article
OBJECTIVE: This study was performed to investigate frequency and antimicrobial susceptibility of pulmonary pathogens in cystic fibrosis (CF) patients.
METHODS: 129 pediatric patients with CF were enrolled in this cross-sectional study. Microbiological cultures were performed based on sputum or pharyngeal swabs. Antibiotic susceptibilities of the isolated bacteria were determined by the disk diffusion method.
RESULTS: The main infecting pathogens were Pseudomonas aeruginosa (38.8%), Klebsiella pneumoniae (11.6%) and Staphyloccus areus (9.3%), respectively. The most active antibiotics included rifampin (91.7% susceptibility), vancomycin (85%) and imipenem (83.5%). Emerging resistance against aminoglycosides was observed.
CONCLUSION: Regarding in vitro susceptibility results, cyclic treatment of long-term oral azithromycin and inhaled tobramycin could prophylactically be applied, and during exacerbations, imipenem or ceftazidime in combination with an aminoglycoside such as amikacin could be considered the drugs of choice.
The access to the Brazilian Journal of Infectious Diseases is restricted to the members of the
Sociedade Brasileira de Infectologia (Brazilian Society of Infectology).
For the first access, please enter your e-mail registered at the site as the login and the password 1234, for subsequent update of your information.
To become a member, click here
For more information or questions please send an e-mail to firstname.lastname@example.org